Project HOPE UK has presented over 7,000 units of ciprofloxacin, donated by Bayer, to the Ministry of Health in Zanzibar for use in hospitals and rural clinics.
The antibiotic, which is effective against a broad spectrum of bacterial infections such as E. coli and Salmonella, will improve the safety of healthcare facilities and protect vulnerable people.
“Thanks to Bayer, we are providing greater access to more effective medicines that result in improved care for patients in Zanzibar,” said Ellie Higgins, Manager for Strategic Partnerships at Project HOPE UK. “Patients will leave the hospital more quickly because they now have access to a powerful antibiotic.”
Professor Wolfgang Plischke, Head of Bayer HealthCare, commented: “We are delighted to work with the team of Project HOPE and the Ministry of Health in Zanzibar to address the medical needs of patients in Zanzibar to help speed up the recovery process for patients in need in both urban and rural communities.”
Bayer HealthCare works in partnership with other organisations to support the health of communities through long-term improvements in healthcare, hygiene, medical training, health education and access to medicines.
Project HOPE will work with Zanzibar’s Ministry of Health to carry out distribution of the donated antibiotic and follow up on its use.
Ciprofloxacin is a synthetic antibiotic with rapid bactericidal effects, especially against Gram-negative bacteria.
Founded in 1958, Project HOPE (Health Opportunities for People Everywhere) is a charitable foundation dedicated to helping communities develop sustainable health solutions worldwide.
Based in Germany, Bayer HealthCare is a subgroup of Bayer AG.